NIH LIVE QA - NIH LIVE QA - POCTRN
In response to the COVID-19 pandemic, the RADx program was formed to accelerate the development, validation, and commercialization of innovative point-of-care and home-based tests, as well as improvements to clinical laboratory tests, that can directly detect SARS-CoV-2, the virus that causes COVID-19.
NIH LIVE QA Session
RADX Delivering new COVID-19 Testing Tech to Meet US Demand
Watch Dr. Francis Collins, NIH Director, and Dr. Bruce Tromberg, NIBIB Director discuss the first seven technologies contracted with the NIH RADx program.